miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.

OBJECTIVES The aim of this study was to determine expression levels of miR-433 in oral squamous cell carcinomas (OSCCs) and adjacent normal tissues, and explore its biological functions in OSCCs. METHODS miR-433 level in oral squamous cell carcinomas (OSCCs) and adjacent normal tissues was tested by real-time qPCR. The effect of miR-433 on cell growth was detected by MTT and colony formation assays. The tumorigenicity of miR-433 transfected OSCCs was evaluated in nude mice model. Transwell and wound healing assays were performed to detect the effect of miR-433 on OSCCs cell invasion and migration. Luciferase reporter gene assays were performed to identify the interaction between miR-433 and 3'UTR of HDAC6 mRNA. The protein level of HDAC6, BCL2, CCNE1, MMP1 and MMP9 was determined by Western blotting. Immunohistochemistry analysis was performed to detect the expression of HDAC6 in oral squamous cell carcinomas (OSCCs) and adjacent normal tissues. RESULTS We found that miR-433 was frequently down-regulated in OSCCs compared with adjacent normal tissues. Restoring miR-433 expression in OSCC cells dramatically suppressed cells growth, invasion and migration. Importantly, our data showed that miR-433 downregulated the expression of HDAC6 through directly targeting its 3'UTR. CONCLUSION Our data suggest that miR-433 exerts its tumor suppressor function by targeting HDAC6, leading to the inhibition of OSCC cell growth, invasion and migration, which suggest that miR-433 may be potential target for diagnostic and therapeutic applications in OSCC.

[1]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[2]  N. K. Clebis,et al.  Prognostic significance of the anatomical location and TNM clinical classification in oral squamous cell carcinoma. , 2008, Medicina oral, patologia oral y cirugia bucal.

[3]  Wen-Chang Ko,et al.  Copy number changes of CRISP3 in oral squamous cell carcinoma. , 2012, Oncology letters.

[4]  J. Jia,et al.  MicroRNAs: new actors in the oral cancer scene. , 2011, Oral oncology.

[5]  Qiang Sun,et al.  Characterization of Circulating MicroRNA Expression in Patients with a Ventricular Septal Defect , 2014, PloS one.

[6]  Zhihong Yang,et al.  MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding Protein* , 2013, The Journal of Biological Chemistry.

[7]  O. Kent,et al.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.

[8]  K. Yang,et al.  MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets , 2014, Cell proliferation.

[9]  Hao Ren,et al.  Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. , 2012, World journal of gastroenterology.

[10]  Guisheng Song,et al.  A Conserved Gene Structure and Expression Regulation of miR-433 and miR-127 in Mammals , 2009, PloS one.

[11]  Kou-Juey Wu,et al.  Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity , 2010, Cancer science.

[12]  Takeshi Onda,et al.  Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. , 2006, International journal of oncology.

[13]  C. Scully,et al.  Oral squamous cell carcinoma overview. , 2009, Oral oncology.

[14]  S. Choi,et al.  Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy , 2008, Journal of dental research.

[15]  R. Kalluri,et al.  Molecular Pathways Molecular Pathways : MicroRNAs as Cancer Therapeutics , 2012 .

[16]  H. Lan,et al.  The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway. , 2013, Kidney international.

[17]  F. Wang,et al.  The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer , 2013, International journal of molecular sciences.

[18]  Jianhua Huang,et al.  Regulatory effects of miRNA on gastric cancer cells , 2014, Oncology letters.

[19]  E. Genden,et al.  Neck disease and distant metastases. , 2003, Oral oncology.

[20]  S. Xiong,et al.  Mitochondria-mediated apoptosis in mammals , 2014, Protein & Cell.

[21]  F. Beuschlein,et al.  ACTH-dependent regulation of microRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland. , 2012, Endocrinology.

[22]  J. Koh,et al.  MiR-433 mediates ERRγ-suppressed osteoblast differentiation via direct targeting to Runx2 mRNA in C3H10T1/2 cells. , 2013, Life sciences.

[23]  A. Sabichi,et al.  Frontiers in cancer prevention research. , 2003, Cancer research.

[24]  G. Pitiyage,et al.  Molecular markers in oral epithelial dysplasia: review. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[25]  C. Scully,et al.  Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes. , 2009, Oral oncology.

[26]  P. Lichter,et al.  Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma , 2010, Genes, chromosomes & cancer.

[27]  B. Su,et al.  Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. , 2013, Molecular medicine reports.

[28]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[29]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[30]  R. Ala-aho,et al.  Collagenases in cancer. , 2005, Biochimie.

[31]  B. Ebert,et al.  miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation , 2013, Leukemia.